AstraZeneca

AstraZeneca

AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialization of prescription medicines, primarily for the treatment of diseases in three therapy areas - Oncology, Cardiovascular, Renal & Metabolism and Respiratory. AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide.


PORTFOLIO-WIDE LEADERSHIP COMMITMENTS

98% GHG reduction by 2025
5% reduction in Energy Intensity by 2025


ASTRA ZENECA IS PARTICIPATING IN THE FOLLOWING DOE PROGRAMS:

Better Climate Challenge   Better Plants Challenge
Low Carbon Pilot   Waste Reduction Network

 

AstraZeneca received a 2018 Better Project Award for installing a 2.5 MW natural gas fired-combined heat and power system at its Gaithersburg, Maryland, facility, helping the site achieve 13.9% energy savings over the previous year.

NAICS 325, Chemical Manufacturing

Date of Pledge: October 2010

Climate Challenge Commitment
16Facilities
Plants Challenge Commitment
16Facilities
GHG Emissions Goals
98%Reduction by 2025
Progress
Better Plants Energy Performance
5% Reduction in Energy Intensity
Progress